Aquatic Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Aquatic Capital Management's GILD Position: Q2 2026 in Review
Aquatic Capital Management reduced its Gilead Sciences (GILD) stake by 38% in Q2 2026, selling an estimated $2.35M and leaving 29,446 shares worth $3.72M. The position accounts for 0.13% of the portfolio, ranked #204.
Aquatic Capital Management first reported a position in GILD in Q4 2021 and has held it in 6 quarters since. The position peaked at $16.7M in Q1 2024. 2,290 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Aquatic Capital Management held 29,446 shares of Gilead Sciences worth $3.72M as of Q2 2026.
- Aquatic Capital Management sold 17,827 Gilead Sciences shares in Q2 2026, an estimated $2.35M.
- Gilead Sciences made up 0.13% of Aquatic Capital Management's portfolio in Q2 2026, its #204 holding.
- Aquatic Capital Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 6 quarters since.
- Aquatic Capital Management's Gilead Sciences position peaked at $16.7M in Q1 2024.
- 2,290 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.